RxDoctor Payments Data
★ My doctorsLook up a doctor →

Deena Rodney

Family · Maitland, FLNPI 1932408028

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (58.4%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by AstraZeneca at 54.8% of the total. 2025 is the largest year on record at $97,877, 2.5 times the $39,798 reported in 2021. Among family clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$322,542in general payments, 2019–2025

Across 1,790 payments — averaging $180.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$177K
  • AbbVie$41K
  • UCB, Inc.$34K
  • Johnson & Johnson$28K
  • Amgen$11K
  • Takeda Pharmaceuticals U.S.A., Inc.$11K
  • plus $20K from 54 others

What the payments were for

  • Consulting fees$36,82111%
  • Speaking & faculty fees$188,36658%
  • Travel & lodging$60,40519%
  • Food & beverage$36,63311%
  • Education$3160%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca448$176,781
AbbVie(2 entities)228$41,336
UCB, Inc.82$34,496
Johnson & Johnson(2 entities)65$28,291
Amgen(2 entities)62$11,033
Takeda Pharmaceuticals U.S.A., Inc.41$10,960
Argenx US, Inc.85$4,236
Neurocrine Biosciences, Inc.112$2,145
Biogen66$1,498
Novartis126$1,028
Sanofi36$808
Lilly USA, LLC39$664
Teva Pharmaceuticals USA, Inc.38$623
EMD Serono, Inc.27$593
Lundbeck LLC22$588
Bristol Myers Squibb29$571
Janssen Scientific Affairs, LLC4$499
Genentech USA, Inc.17$477
Eisai Inc.15$453
Pfizer22$428
Catalyst Pharmaceuticals, Inc.7$385
Supernus Pharmaceuticals, Inc.19$367
Biohaven Pharmaceuticals, Inc.10$317
TG Therapeutics, Inc.11$317
Jazz Pharmaceuticals Inc.11$290
Amneal Pharmaceuticals LLC15$242
MDD US Operations, LLC15$223
CSL Behring9$222
Tanabe Pharma America, Inc.9$169
Neurelis, Inc.9$161
SK Life Science, Inc.6$155
Scilex Pharmaceuticals Inc.8$146
Vanda Pharmaceuticals Inc.6$136
Axsome Therapeutics, Inc.5$130
Biohaven Pharmaceutical Holding Company Ltd.6$129
Avadel CNS Pharmaceuticals, LLC5$121
Sunovion Pharmaceuticals Inc.7$120
Otsuka America Pharmaceutical, Inc.5$108
Acadia Pharmaceuticals Inc7$104
Upsher-smith Laboratories LLC4$88
E.r. Squibb & Sons, L.L.C.1$88
Averitas Pharma Inc.3$79
Sumitomo Pharma America, Inc.4$77
Grifols USA, LLC4$71
GE HealthCare3$66
Xeris Pharmaceuticals, Inc.3$65
Kyowa Kirin, Inc.3$65
Alnylam Pharmaceuticals Inc.2$56
Livanova USA, Inc.3$50
Banner Life Sciences, LLC2$48
Avanir Pharmaceuticals, Inc.2$45
Acorda Therapeutics, Inc2$41
Arbor Pharmaceuticals, Inc.3$39
Sandoz1$31
Mallinckrodt Hospital Products Inc.1$30
Merz Pharmaceuticals, LLC1$26
Aucta Pharmaceuticals, Inc.2$25
Avion Pharmaceuticals1$20
Mylan Specialty L.p.1$20
Merck1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$322,542 in reported general payments places this provider in the 95th percentile of 14,618 family providers in Florida.

See all family providers in Florida →

Most prescribed under Part D

DrugClaimsCost to plans & patients
RivastigmineRivastigmine Tartrate12$762
Memantine Hcl13$730
Buspirone Hcl14$127

Paid to pharmacies, not to this prescriber.

Other family in Maitland

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →